{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:23:05Z","timestamp":1761092585227,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12350-017-1037-2","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T14:13:24Z","timestamp":1502979204000},"page":"493-496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The logic and challenges of imaging sarcoidosis with whole body FDG PET"],"prefix":"10.1016","volume":"26","author":[{"given":"Roberto C.","family":"Valentin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Bhambhvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1007\/s12350-017-1037-2_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1007\/s12350-017-1037-2_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0002-9343(97)89518-6","article-title":"Sarcoidosis mortality in the United States 1979-1991: An analysis of multiple-cause mortality data","volume":"100","author":"Gideon","year":"1996","journal-title":"Am J Med"},{"issue":"4","key":"10.1007\/s12350-017-1037-2_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1253\/jcj.44.264","article-title":"Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. II. Myocarditis","volume":"44","author":"Sekiguchi","year":"1980","journal-title":"Jpn Circ J"},{"issue":"1","key":"10.1007\/s12350-017-1037-2_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1378\/chest.103.1.253","article-title":"Myocardial sarcoidosis","volume":"103","author":"Sharma","year":"1993","journal-title":"Chest"},{"issue":"6","key":"10.1007\/s12350-017-1037-2_bib5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"issue":"6","key":"10.1007\/s12350-017-1037-2_bib6","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: Diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"issue":"1","key":"10.1007\/s12350-017-1037-2_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2967\/jnumed.112.115121","article-title":"Advanced imaging of cardiac sarcoidosis","volume":"55","author":"Schatka","year":"2014","journal-title":"J Nucl Med"},{"issue":"24","key":"10.1007\/s12350-017-1037-2_bib8","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1093\/eurheartj\/ehm456","volume":"28","author":"Cooper","year":"2007","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1007\/s12350-017-1037-2_bib9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s12350-009-9145-2","article-title":"Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET","volume":"17","author":"Buckley","year":"2010","journal-title":"J Nucl Cardiol"},{"issue":"20","key":"10.1007\/s12350-017-1037-2_bib10","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1007\/s12350-017-1037-2_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1007\/s12350-017-1037-2_bib12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1007\/s12350-017-1037-2_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCIMAGING.112.000289","article-title":"Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by (1)(8)F- fluorodoexyglucose positron emission tomography?","volume":"6","author":"Mc Ardle","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1007\/s12350-017-1037-2_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am College Cardiol"},{"key":"10.1007\/s12350-017-1037-2_bib15","unstructured":"Patel DC, Gunasekaran SS, Goettl C, Sweiss NJ, Lu Y. FDG PET-CT findings of extra-thoracic sarcoid are associated with cardiac sarcoid: A rationale for using FGD PET-CT for cardiac sarcoid evaluation. J Nucl Cardiol 2017."},{"issue":"11","key":"10.1007\/s12350-017-1037-2_bib16","first-page":"181","article-title":"Radiological diagnosis in lung disease: Factoring treatment options into the choice of diagnostic modality","volume":"111","author":"Wielputz","year":"2014","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"10.1007\/s12350-017-1037-2_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"10.1007\/s12350-017-1037-2_bib18","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s12350-011-9422-8","article-title":"Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake","volume":"18","author":"Harisankar","year":"2011","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1007\/s12350-017-1037-2_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12350-012-9653-3","article-title":"Clinical value of a high-fat and low-carbohydrate diet before FDG-PET\/CT for evaluation of patients with suspected cardiac sarcoidosis","volume":"20","author":"Soussan","year":"2013","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1007\/s12350-017-1037-2_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"Manabe","year":"2016","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1007\/s12350-017-1037-2_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2967\/jnumed.115.166884","article-title":"Additional heparin preadministration improves cardiac glucose metabolism suppression over low-carbohydrate diet alone in (1)(8)F-FDG PET imaging","volume":"57","author":"Scholtens","year":"2016","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1007\/s12350-017-1037-2_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/RLU.0000000000001465","article-title":"Suppression of myocardial 18F-FDG uptake through prolonged high-fat, high-protein, and very-low-carbohydrate diet before FDG-PET\/CT for evaluation of patients with suspected cardiac sarcoidosis","volume":"42","author":"Lu","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1007\/s12350-017-1037-2_bib23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12350-016-0522-3","article-title":"ASNC imaging guidelines\/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures","volume":"23","author":"Dilsizian","year":"2016","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"10.1007\/s12350-017-1037-2_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","article-title":"Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations","volume":"28","author":"Ishida","year":"2014","journal-title":"Ann Nucl Med"},{"issue":"8","key":"10.1007\/s12350-017-1037-2_bib25","first-page":"1341","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"15","key":"10.1007\/s12350-017-1037-2_bib26","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/eurheartj\/ehi180","article-title":"Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis","volume":"26","author":"Ishimaru","year":"2005","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1007\/s12350-017-1037-2_bib27","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s12350-016-0443-1","article-title":"Evaluation of a low-carbohydrate diet-based preparation protocol without fasting for cardiac PET\/MR imaging","volume":"24","author":"Nensa","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"12","key":"10.1007\/s12350-017-1037-2_bib28","first-page":"1989","article-title":"Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1007\/s12350-017-1037-2_bib29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11886-013-0370-6","article-title":"18F-FDG PET\/CT for the assessment of myocardial sarcoidosis","volume":"15","author":"Skali","year":"2013","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"10.1007\/s12350-017-1037-2_bib30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"issue":"12","key":"10.1007\/s12350-017-1037-2_bib31","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","article-title":"Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis","volume":"3","author":"Tahara","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1007\/s12350-017-1037-2_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"10.1007\/s12350-017-1037-2_bib33","first-page":"1030","article-title":"Identification of cardiac sarcoidosis with (13)N-NH(3)\/(18)F-FDG PET","volume":"44","author":"Yamagishi","year":"2003","journal-title":"J Nucl Med"},{"issue":"supplement 1","key":"10.1007\/s12350-017-1037-2_bib34","first-page":"296","article-title":"Assessment of treatment response of cardiac and extra-cardiac sarcoidosis by using metabolic and volumetric FDG PET\/CT parameters","volume":"55","author":"Promteangtrong","year":"2014","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1007\/s12350-017-1037-2_bib35","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s12350-014-9921-5","article-title":"Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"21","author":"Waller","year":"2014","journal-title":"J Nucl Cardiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-017-1037-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-017-1037-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123061305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123061305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-017-1037-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:04:45Z","timestamp":1761026685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123061305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1071358123061305"],"URL":"https:\/\/doi.org\/10.1007\/s12350-017-1037-2","relation":{},"ISSN":["1071-3581"],"issn-type":[{"type":"print","value":"1071-3581"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The logic and challenges of imaging sarcoidosis with whole body FDG PET","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-017-1037-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}